Q87K (p.Gln87Lys) variant of ABL2 (Tyrosine-protein kinase ABL2)
Q87K (p.Gln87Lys) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not specified. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes population frequency data.
Q87K (p.Gln87Lys) variant details
- p.Gln87Lys
- gnomAD rs1308100649
- Uncertain significance
- not specified
- Missense
- Variant Prioritization Score for Impact Estimate 0.358
- REVEL 0.09
- CADD 23.10
- PolyPhen-2 0.07
- SIFT 0.04
- ClinVar: Uncertain significance (not specified)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Population evidence available